Logo
x

Search

Subscribe Now

Oncology Pipeline

Merck to Acquire VelosBio for $2.75B

Merck to Acquire VelosBio for $2.75B

  • November 5, 2020
Astrazeneca Expands Existing Deal with Innate Pharma to Strengthen its Oncology Pipeline

Astrazeneca Expands Existing Deal with Innate Pharma to Strengthen its Oncology Pipeline

  • October 23, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.